Skin injection of Ebi3 improved skin fibrosis in SSc mice models, further suggesting that IL-35 may have potential therapeutic effects to improve fibrosis during the pathogenesis of SSc [65]. The gene discussed is EBI3; the disease is systemic sclerosis.